BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 26, 2010
View Archived Issues
Anti-Addiction Drug Breaks Dopamine's Vicious Cycle
Read More
NewCo News: Radical Therapeutix Works to Protect Precious Heart Tissue
Read More
Stock Movers
Read More
Other News To Note
Read More
Financings Roundup
Read More
Somaxon Secures Partner P&G to Co-Promote Insomnia Drug
San Diego-based Somaxon Pharmaceuticals Inc. plans to launch its Silenor insomnia drug in September with the help of Proctor & Gamble Co., which will co-promote the prescription drug in the U.S. (BioWorld Today)
Read More
Neuralstem Files Spinal Cord IND Amid Stem Cell Hubbub
Read More